Guangdong Biolight Meditech Co Ltd300246
± MixedCapitalrelevance
Controlling shareholder plans change of control; trading suspended, outcome uncertain.

Biolight announced that its controlling shareholder is planning a change of control. Trading in the company's stock and convertible bonds will be suspended starting August 3, with the halt expected to last no more than two trading days. The convertible bonds, known as Biolight Convertible Bonds, will also suspend conversion into shares.
Guangdong Biolight Meditech Co LtdControlling shareholder plans change of control; trading suspended, outcome uncertain.